• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Thomas R. Spitzer, MD


  • Yeh AC, Brunner AM, Spitzer TR, Chen YB, Coughlin E, McAfee S, Ballen K, Attar E, Caron M, Preffer FI, Yeap BY, Dey BR.Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2014 May;20(5):730-4.
  • Omer AK, Kim HT, Yalamarti B, McAfee SL, Dey BR, Ballen KK, Attar E, Chen YB, Spitzer TR.Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults.Am J Hematol. 2014 Mar 25.
  • Brunner AM, Kim HT, Coughlin E, Alyea EP, Armand P, Ballen KK, Cutler C, Dey BR, Glotzbecker B, Koreth J, McAfee SL, Spitzer TR, Soiffer RJ, Antin JH, Ho VT, Chen YB.Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.Biol Blood Marrow Transplant. 2013 Sep;19(9):1374-80.
  • Omer AK, Ziakas PD, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee SL, Dey BR, Attar E, Chen YB, Spitzer TR, Mylonakis E, Ballen KK.Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.Biol Blood Marrow Transplant. 2013 Aug;19(8):1190-6.
  • Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT.Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia.Biol Blood Marrow Transplant. 2013 Apr 2.
  • Matar AJ, Crepeau RL, Pathiraja V, Robson S, Fishman JA, Spitzer TR, Sachs DH, Huang CA, Duran-Struuck R.Effects of mobilization regimens in donors on outcomes of hematopoietic cell transplantation in miniature Swine.Comp Med. 2012;62(6):487-94.
  • El-Rayess HM, Refaat MM, Post MD, Spitzer TR, Dey B.Chronic graft-versus-host disease with skin signs suspicious for squamous cell carcinoma.Acta Oncol. 2012 Dec 3.
  • Spitzer TR.Microtransplantation: a new paradigm for the separation of graft versus host disease and graft versus tumor?.J Clin Oncol. 2012 Nov 20;30(33):4051-2.
  • Ballen K, Mendizabal AM, Cutler C, Politikos I, Jamieson K, Shpall EJ, Dey BR, Attar E, McAfee S, Delaney C, McCarthy P, Ball ED, Kamble R, Avigan D, Maziarz RT, Ho VT, Koreth J, Alyea E, Soiffer R, Wingard JR, Boussiotis V, Spitzer TR, Antin JH.Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.Biol Blood Marrow Transplant. 2012 Dec;18(12):1851-8.
  • Duran-Struuck R, Matar A, Crepeau R, Gusha A, Schenk M, Hanekamp I, Pathiraja V, Spitzer TR, Sachs DH, Huang CA.Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation Swine model.Biol Blood Marrow Transplant. 2012 Nov;18(11):1629-37.
  • Crepeau R, Matar A, Spitzer TR, Robson S, Pathiraja V, Sachs DH, Huang CA, Duran-Struuck R.Edema and tetraparesis in a miniature pig after allogeneic hematopoietic cell transplantation.Comp Med. 2012 Aug;62(4):298-302.
  • Spitzer TR, Dey BR, Chen YB, Attar E, Ballen KK.The expanding frontier of hematopoietic cell transplantation.Cytometry. Part B, Clinical Cytometry. 2012 Sep;82(5):271-9.
  • Chen YB, McDonough S, Hasserjian R, Chen H, Coughlin E, Illiano C, Park IS, Jagasia M, Spitzer TR, Cutler CS, Soiffer RJ, Ritz J.Expression of CD30 in patients with acute graft-versus-host disease.Blood. 2012 Jul 19;120(3):691-6.
  • Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey BR, Ballen K, Delmonico F, Saidman S, Sachs DH, Cosimi AB.Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.Transplantation. 2011 Mar 27;91(6):672-6.
  • LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman SL, Spitzer TR, Tolkoff-Rubin N, Cosimi AB, Sachs DH, Sykes M.Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.Transplantation. 2010 Dec 27;90(12):1607-15.
  • Heher EC, Spitzer TR.Hematopoietic stem cell transplantation in patients with chronic kidney disease.Semin Nephrol. 2010 Nov;30(6):602-14.
  • Dey BR, Chung SS, Spitzer TR, Zheng H, Macgillivray TE, Seldin DC, McAfee S, Ballen K, Attar E, Wang T, Shin J, Newton-Cheh C, Moore S, Sanchorawala V, Skinner M, Madsen JC, Semigran MJ.Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.Transplantation. 2010 Oct 27;90(8):905-11.
  • Heher EC, Goes NB, Spitzer TR, Raje NS, Humphreys BD, Anderson KC, Richardson PG.Kidney disease associated with plasma cell dyscrasias.Blood. 2010 Sep 2;116(9):1397-404. Review.
  • Cutler C, Stevenson K, Kim HT, Brown J, McDonough S, Herrera M, Reynolds C, Liney D, Kao G, Ho V, Armand P, Koreth J, Alyea E, Dey BR, Attar E, Spitzer T, Boussiotis VA, Ritz J, Soiffer R, Antin JH, Ballen K.Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.Bone Marrow Transplant. 2010 Aug 9.
  • Ballen KK, Cutler C, Yeap BY, McAfee SL, Dey BR, Attar EC, Chen YB, Haspel RL, Liney D, Koreth J, Ho V, Alyea EP, Soiffer RJ, Spitzer TR, Antin JH.Donor Derived Second Hematologic Malignancies after Cord Blood Transplantation.Biol Blood Marrow Transplant. 2010 Jul;16(7):1025-31.
  • Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, McDonald GB, Guinan EC.Defibrotide for the treatment of severe hepatic veno-occlusive disease and multi-organ failure post stem cell transplantation: a multi-center, randomized, dose-finding trial.Biol Blood Marrow Transplant. 2010 Jul;16(7):1005-17.
  • Krause DS, Spitzer TR, Stowell CP.The concentration of CD44 is increased in hematopoietic stem cell grafts of patients with acute myeloid leukemia, plasma cell myeloma, and non-Hodgkin lymphoma.Arch Pathol Lab Med. 2010 Jul;134(7):1033-8.
  • Brown JA, Stevenson K, Kim HT, Cutler C, Ballen K, McDonough S, Reynolds C, Herrera M, Liney D, Ho V, Kao G, Armand P, Koreth J, Alyea E, McAfee S, Attar E, Dey B, Spitzer T, Soiffer R, Ritz J, Antin JH, Boussiotis VA.Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.Blood. 2010 May 20;115(20):4111-9.
  • Duran-Struuck R, Cho PS, Teague AG, Fishman B, Fishman AS, Hanekamp JS, Moran SG, Wikiel KJ, Ferguson KK, Lo DP, Duggan M, Arn JS, Billiter B, Horner B, Houser S, Yeap BY, Westmoreland SV, Spitzer TR, McMorrow IM, Sachs DH, Bronson RT, Huang CA.Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias.Veterinary Immunology And Immunopathology. 2010 Jun 15;135(3-4):243-56.
  • Chen YB, Hochberg EP, Feng Y, Neuberg D, Rawal B, Motyckova G, Fisher DC, McAfee SL, Spitzer TR, Lacasce AS.Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to patients who failed cyclophosphamide, adriamycin, vincristine, and prednisone.Leuk Lymphoma. 2010 May;51(5):789-96.
  • Ulrickson M, Aldridge J, Kim HT, Hochberg EP, Hammerman P, Dube C, Attar E, Ballen KK, Dey BR, McAfee SL, Spitzer TR, Chen YB.Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.Biol Blood Marrow Transplant. 2009 Nov;15(11):1447-54.
  • Dey BR, Spitzer TR, Hasserjian RP.Case records of the Massachusetts General Hospital. Case 28-2009. A 68-year-old man with fatigue, cough, and peripheral-blood monocytosis.N Engl J Med. 2009 Sep 10;361(11):1099-106.
  • Chen YB, Kim HT, McDonough S, Odze RD, Yao X, Lazo-Kallanian S, Spitzer TR, Soiffer R, Antin JH, Ritz J.Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2009 Sep;15(9):1066-76.
  • Heher EC,Spitzer TR,Goes NB.Light chains: heavy burden in kidney transplantation.Transplantation. 2009 Apr 15;87(7):947-52. Review.
  • Delaney M,Cutler CS,Haspel RL,Yeap BY,McAfee SL,Dey BR,Attar E,Kao G,Alyea EP,Koreth J,Ho VT,Saidman S,Liney D,Sese D,Soiffer RJ,Spitzer TR,Antin JH,Ballen KK.High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.Transfusion. 2009 May;49(5):995-1002.
  • Yusuf RZ, Dey B, Yeap BY, McAfee S, Attar E, Sepe PS, Dube C, Spitzer TR, Ballen KK.Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.Bone Marrow Transplant. 2009 Jan;43(1):37-42.
  • Ting DT, Spitzer TR, Chaudhary A, Muzikansky A, Colby C, Power K, McAfee S, Ballen K, Attar E, Saidman SL, Preffer F, Sykes M, Dey BR.Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT.Bone Marrow Transplant. 2008 Sep;42(5):329-35.
  • Haspel RL, Kao G, Yeap BY, Cutler C, Soiffer RJ, Alyea EP, Ho VT, Koreth J, Dey BR, McAfee SL, Attar EC, Spitzer T, Antin JH, Ballen KK.Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.Bone Marrow Transplant. 2008 Mar;41(6):523-9.
  • Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH.HLA-mismatched renal transplantation without maintenance immunosuppression.N Engl J Med. 2008 Jan 24;358(4):353-61.
  • Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT.Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.Biol Blood Marrow Transplant. 2008 Jan;14(1):59-66.
  • Chen YB, Spitzer TR.Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors.Leukemia. 2008 Jan;22(1):31-41. Review.
  • Shaffer J, Villard J, Means TK, Alexander S, Dombkowski D, Dey BR, McAfee S, Ballen KK, Saidman S, Preffer FI, Sachs DH, Spitzer TR, Sykes M.Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.Exp Hematol. 2007 Jul;35(7):1140-52.
  • Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K, Dey BR, Attar E, McAfee S, Konopleva M, Antin JH, Spitzer TR.Phase I trial of parathyroid hormone to facilitate stem cell mobilization.Biol Blood Marrow Transplant. 2007 Jul;13(7):838-43.
  • Dey BR, Shaffer J, Yee AJ, McAfee S, Caron M, Power K, Ting DT, Colby C, Preffer F, Ballen K, Attar E, Saidman S, Tarbell N, Sachs D, Sykes M, Spitzer TR.Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen.Bone Marrow Transplant. 2007 Jul;40(1):19-27.
  • Park JH, Spitzer T, Kuter DJ.Successful treatment of pure red cell aplasia with autologous stem cell transplantation.Am J Hematol. 2007 Sep;82(9):812-4.
  • Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, Haspel R, Kao G, Liney D, Alyea E, Lee S, Cutler C, Ho V, Soiffer R, Antin JH.Double unrelated reduced-intensity umbilical cord blood transplantation in adults.Biol Blood Marrow Transplant. 2007 Jan;13(1):82-9.
  • Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman SL, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M.Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses.Am J Transplant. 2006 Sep;6(9):2121-33.
  • Cina RA, Wikiel KJ, Lee PW, Cameron AM, Hettiarachy S, Rowland H, Goodrich J, Colby C, Spitzer TR, Neville DM, Huang CA.Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation.Transplantation. 2006 Jun 27;81(12):1677-85.
  • Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, Zhang MJ, Horowitz MM.Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research.Br J Haematol. 2006 Mar;132(6):755-69.
  • Ballen KK, Colvin G, Dey BR, Porter D, Westervelt P, Spitzer TR, Quesenberry PJ.Cellular immune therapy for refractory cancers: novel therapeutic strategies.Exp Hematol. 2005 Dec;33(12):1427-35.
  • Sykes M, Spitzer TR.Protecting the host naturally.Nat Med. 2005 Nov;11(11):1164-5.
  • Dey BR, McAfee S, Colby C, Cieply K, Caron M, Saidman S, Preffer F, Shaffer J, Tarbell N, Sackstein R, Sachs D, Sykes M, Spitzer TR.Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation.Br J Haematol. 2005 Feb;128(3):351-9.
  • Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL, Dey B, McAfee S, Spitzer TR, Sykes M.NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.Exp Hematol. 2003 Oct;31(10):911-23.
  • Friedberg JW, Kim H, Li S, Neuberg D, Boyd K, Daley H, Fisher DC, Gribben JG, Spitzer T, Freedman AS.Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma.Bone Marrow Transplant. 2003 Oct;32(7):681-6.
  • Kraus AB, Shaffer J, Toh HC, Preffer F, Dombkowski D, Saidman S, Colby C, George R, McAfee S, Sackstein R, Dey B, Spitzer TR, Sykes M.Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.Exp Hematol. 2003 Jul;31(7):609-21.
  • Daly A, McAfee S, Dey B, Colby C, Schulte L, Yeap B, Sackstein R, Tarbell NJ, Sachs D, Sykes M, Spitzer TR.Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants.Biol Blood Marrow Transplant. 2003 Jun;9(6):373-82.
  • Spitzer TR, McAfee SL, Dey BR, Colby C, Hope J, Grossberg H, Preffer F, Shaffer J, Alexander SI, Sachs DH, Sykes M.Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies.Transplantation. 2003 May 27;75(10):1748-51.
  • Dey BR, McAfee S, Colby C, Sackstein R, Saidman S, Tarbell N, Sachs DH, Sykes M, Spitzer TR.Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.Biol Blood Marrow Transplant. 2003 May;9(5):320-9.
  • Toh HC, Spitzer TR, Preffer F, Alexander SI, McAfee S, Dombkowski D, Clark JS, Colby C, Saidman S, Sackstein R, Sykes M.Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplant.Cytokines Cell Mol Ther. 2002 Dec;7(2):43-7.
  • Spitzer TR.The expanding applications of non-myeloablative stem cell transplantation.Pediatr Transplant. 2003;7 Suppl 3:95-100.
  • Bühler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi AB.Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.Transplantation. 2002 Nov 27;74(10):1405-9.
  • Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC.Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.Blood. 2002 Dec 15;100(13):4337-43.
  • Webb IJ, Friedberg W, Gribben JG, Fisher DC, Spitzer T, Neuberg D, Jallow H, Kim H, Houde H, Monroy R, Schmittling R, Freedman AS.Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma.Biol Blood Marrow Transplant. 2002;8(8):429-34.
  • Colby C, Koziol S, McAfee SL, Yeap B, Spitzer TR.High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant.Bone Marrow Transplant. 2002 Mar;29(6):467-72.
  • Sykes M, Spitzer TR.Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologic malignancies in experimental and clinical studies.Cancer Treat Res. 2002;110:79-99.
  • Dey BR, McAfee S, Sackstein R, Colby C, Saidman S, Weymouth D, Poliquin C, Vanderklish J, Sachs DH, Sykes M, Spitzer TR.Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.Biol Blood Marrow Transplant. 2001;7(11):604-12.
  • Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, Spitzer T, Weisdorf D.Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood an.Biol Blood Marrow Transplant. 2001;7(9):473-85.
  • Seiden MV, Spitzer TR, McAfee S, Fuller AF.Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma.Gynecol Oncol. 2001 Nov;83(2):412-4.
  • Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J.Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.Bone Marrow Transplant. 2000 Jul;26(2):203-10.
  • Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, Saidman S, Weyouth DW, Preffer F, Poliquin C, Foley A, Cox B, Andrews D, Sachs DH, Sykes M.Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.Biol Blood Marrow Transplant. 2000;6(3A):309-20.
  • Spitzer TR.Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism.Oncologist. 2000;5(3):215-23.
  • Toh HC, McAfee SL, Sackstein R, Multani P, Cox BF, Garcia-Carbonero R, Colby C, Spitzer TR.High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study.Bone Marrow Transplant. 2000 Jan;25(1):19-24.
  • Colby C, Chang Q, Fuchimoto Y, Ferrara V, Murphy M, Sackstein R, Spitzer TR, White-Scharf ME, Sachs DH.Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine.Transplantation. 2000 Jan 15;69(1):135-40.
  • Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR.Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.Bone Marrow Transplant. 1999 Oct;24(8):891-5.
  • Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.Bone Marrow Transplant. 1999 Oct;24(8):897-902.
  • Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB.Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.Transplantation. 1999 Aug 27;68(4):480-4.
  • Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, Andrews DM, Colby C, Sackstein R, Sachs DH, Spitzer TR.Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.Lancet. 1999 May 22;353(9166):1755-9.
  • Kozlowski T, Shimizu A, Lambrigts D, Yamada K, Fuchimoto Y, Glaser R, Monroy R, Xu Y, Awwad M, Colvin RB, Cosimi AB, Robson SC, Fishman J, Spitzer TR, Cooper DK, Sachs DH.Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.Transplantation. 1999 Jan 15;67(1):18-30.
  • Colby C, McAfee SL, Finkelstein DM, Spitzer TR.Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation.Bone Marrow Transplant. 1998 May;21(10):1005-10.
  • Chang G, McGarigle C, Spitzer TR, McAfee SL, Harris F, Piercy K, Goetz MN, Antin JH.A comparison of related and unrelated marrow donors.Psychosom Med. 1998 Mar-Apr;60(2):163-7.
  • Colby C, Sykes M, Sachs DH, Spitzer TR.Cellular modulation of acute graft-vs.-host disease.Biol Blood Marrow Transplant. 1997 Dec;3(6):287-93.
  • Colby C, Stoukides CA, Spitzer TR.Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation.Ann Pharmacother. 1996 Oct;30(10):1164-74.
  • Cahill RA, Spitzer TR, Mazumder A.Marrow engraftment and clinical manifestations of capillary leak syndrome.Bone Marrow Transplant. 1996 Jul;18(1):177-84.
  • Spitzer TR, Cirenza E, McAfee S, Foelber R, Zarzin J, Cahill R, Mazumder A.Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue.Bone Marrow Transplant. 1995 Apr;15(4):537-42.
  • Spitzer TR, Bryson JC, Cirenza E, Foelber R, Wallerstadt M, Stout C, Kunka RL, Plagge PB, Dubois A.Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation.J Clin Oncol. 1994 Nov;12(11):2432-8.
  • Spitzer TR, Peters C, Ortlieb M, Tefft MC, Torrisi J, Cahill R, Gadner H, Urban C, Deeg HJ.Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children.Int J Radiat Oncol Biol Phys. 1994 Apr 30;29(1):39-44.
  • Spitzer TR, Areman EM, Cirenza E, Yu M, Dickerson S, Kotula PL, Sacher RA, Cottler-Fox M.The impact of harvest center on quality of marrows collected from unrelated donors.J Hematother. 1994 Spring;3(1):65-70.
  • Spitzer TR, Cottler-Fox M, Sullivan P, Lynch M, Tefft MC, Pickle LW, Cirenza E, Cahill R, Deeg HJ, Sacher R.Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation.Semin Hematol. 1992 Jul;29(3 Suppl 2):123-6.
  • Nakajima K, Smith CV, Mixon A, Sykes M, Guzzetta PC, Spitzer TR, Eckhaus MA, Sachs DH.In vitro and in vivo effects of recombinant human interleukin-2 in naive miniature swine.J Immunother. 1992 Apr;11(3):169-75.
  • Spitzer TR, Zwiebel J, Jacobson RJ.Transplants from the same donor.Ann Intern Med. 1991 Sep 15;115(6):498.
  • Spitzer TR, Cahill R, Cottler-Fox M, Treat J, Sacher R, Deeg HJ.Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.Cancer. 1990 Dec 1;66(11):2346-9.
  • Spitzer TR, Himoe E, Cottler-Fox M, Cahill R, Deeg HJ.Long-term stable mixed chimaerism following allogeneic marrow transplantation for severe aplastic anaemia.Br J Haematol. 1990 Sep;76(1):146-7.
  • Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ.Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.Bone Marrow Transplant. 1989 Sep;4(5):559-65.
  • Spitzer TR, Lazarus HM, Creger RJ, Berger NA.High-dose melphalan, misonidazole, and autologous bone marrow transplantation for the treatment of metastatic colorectal carcinoma. A phase I study.Am J Clin Oncol. 1989 Apr;12(2):145-51.
  • Suzuki T, Sundt TM, Kortz EO, Mixon A, Eckhaus MA, Gress RE, Spitzer TR, Sachs DH.Bone marrow transplantation across an MHC barrier in miniature swine.Transplant Proc. 1989 Feb;21(1 Pt 3):3076-8.